Adient plc
—- Market cap
- $1.54B
- Debt
- +$2.39B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 39% equity / 61% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.54B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: ADNT stock price at discount vs CRSP $20.01 current versus $269.14K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CRSP's multiple
Implied fair value · at ADNT's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ADNT FY 2025 (ended Sep 30, 2025) · CRSP FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 39% equity / 61% debt
Capital structure 96% equity / 4% debt · EV / Revenue 1030.21x
ADNT carries the larger enterprise value at $3.93B against $3.62B; ADNT trades on the lower EV / Revenue multiple (0.27x vs 1030.21x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Adient plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CRISPR THERAPEUTICS AG · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.35x
0.10x
Net debt / EBITDA
Leverage against operating earnings
—
3.18x
Cash and equivalents
Liquid reserves on the balance sheet
—
$1.98B
Total debt
Interest-bearing obligations outstanding
$2.39B
$197.39M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.